MultiOmic Health

MultiOmic Health forges research collaboration with Northern Care Alliance NHS Foundation Trust in diabetic kidney disease

London, United Kingdom, 6th December 2022 / Sciad Newswire / MultiOmic Health, an artificial intelligence-enabled precision medicine discovery company, today announces the signing of a research collaboration agreement with Northern Care Alliance (NCA) NHS Foundation Trust in Manchester, England. MultiOmic will deploy its MOHSAIC platform on de-identified bio-samples and clinical histories previously collected by NCA...

MultiOmic Health and Mesh Bio Partner to Use AI to Develop Precision Medicines and Diagnostics for Chronic Metabolic Disease

London, UK, and Singapore, 30th June 2022: / Sciad Newswire / MultiOmic Health, an artificial intelligence (AI)-enabled drug discovery company, and Mesh Bio, a digital health startup transforming chronic disease management through predictive analytics, today announce their partnership to conduct an observational clinical study on patients with chronic metabolic disease and increased risk of complications...
SCIAD Newswire 7-9 Henrietta Street Covent Garden London, WC2E 8PS

+44 (0)20 3405 7892